Clinical trial Recruiting at 3 sites Observational Ages 15 to 65

Identifying brain lesions in multiple sclerosis using advanced MRI techniques

Official title: Early Identification of Brain Lesions in Multiple Sclerosis With Phase Sensitive Inversion Recovery MRI: A Cross-sectional Study

Run by Benha University · NCT06955832 · Data updated 2026-11-12

This study is testing if a new type of MRI called PSIR can find early brain damage better than regular MRIs in people with Multiple Sclerosis.

Quick facts

Study typeObservational
Ages15 Years to 65 Years
SexAll
Enrollment30 (estimated)
SponsorBenha University
Academic / other
Locations3 sites (Banhā, Qalyubia Governorate and 2 other locations)
StatusRecruiting
StartedJune 2025
Main results expectedJune 2025
Study endsOctober 2025
Registry record updatedMay 18, 2025
Trial IDNCT06955832 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 15-65 years who have been diagnosed with Multiple Sclerosis according to the McDonald criteria.

Probably not a fit

Patients with conditions such as stroke, previous intracranial hemorrhage, or those who cannot undergo MRI scans may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the effectiveness of Phase-Sensitive Inversion Recovery (PSIR) MRI in detecting early brain lesions in patients diagnosed with Multiple Sclerosis (MS). It will compare the diagnostic accuracy of PSIR MRI against conventional T2-weighted and Fluid Attenuated Inversion Recovery MRI sequences. Participants aged 15-65 years will be included based on the 2017 McDonald criteria for MS. The study hypothesizes that PSIR MRI will identify more cortical lesions and correlate better with clinical measures than traditional MRI methods.

Why it matters

Potential benefit: If successful, this study could lead to earlier and more accurate diagnosis of brain lesions in MS patients, potentially improving treatment outcomes.

How similar studies have gone: While the use of advanced MRI techniques in MS is a growing field, this specific approach using PSIR MRI for early lesion detection is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 15-65 years.
* Both sexes.
* Patients with MS according to McDonald Criterion

Exclusion Criteria:

* Age less than 15 years old.
* Patients with stroke or previous intracranial hemorrhage.
* Contraindications to MRI scans.
* MS mimics.

Where it's running

  • Banha University Hospitals
    Banhā, Qalyubia Governorate, Egypt
    Recruiting
  • El Mounira Multiple Sclerosis Unit
    Cairo, Egypt
    Recruiting
  • Naser Institute MS Unit
    Cairo, Egypt
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.